Scholars Central

Research articlePublished 22 Dec 2015

High expression of HIF-2α and its anti-radiotherapy effect in lung cancer stem cells

Authors: J.C. Sun, F. He, W. Yi, M.H. Wan, R. Li, X. Wei, R. Wu, D.L. Niu

Genetics and Molecular Research

Volume 14 · Issue 4 · Pages 18110–18120

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hypoxia-inducible factor-2 alpha (HIF-2α) has been shown to regulate cell stemness, although the expression and effects of HIF-2α in lung cancer stem cells remained unclear. This study investigated HIF-2α expression in lung cancer stem cells, as well as the relationship between HIF-2α expression and radioresistance in lung cancer cells. Stem-like cells (CD133+) in the non-small-cell lung cancer cell line A549 were enriched by serum-free culture conditions, and CD133+ cells were sorted via fluorescence-activated cell sorting. A549 cells were treated with middle-infrared radiation, and the level of HIF-2α expression was determined by a quantitative polymerase chain reaction assay and western blot analysis. The level of HIF-2α expression in tissue sections from 50 cases of clinically confirmed non-small-cell lung cancer was determined via immunohistochemical analysis, and its correlation with prognosis after radiotherapy was analyzed. HIF-2α levels in CD133+ cells were significantly higher than those in CD133- cells (P = 0.032). However, after radiation treatment, these levels were significantly upregulated in both CD133+ and CD133- cells (P = 0.031 and P = 0.023, respectively). After irradiation, the proportions of apoptotic, dead, and autophagic CD133+ A549 cells were considerably lower than those of CD133- A549 cells (P < 0.05). Furthermore, the recovery of carcinoembryonic antigen to pre-radiation levels was more rapid in lung cancer patients with high levels of HIF-2α expression, and these patients had shorter survival times (P = 0.018). HIF-2α is highly expressed in lung cancer stem cells, which may lead to radioresistance. In conclusion, HIF-2α is a potential prognostic marker for lung cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGenetics and Molecular Research
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “J.C. Sun”
  • BylineArticles whose byline prints “F. He”
  • BylineArticles whose byline prints “W. Yi”
  • BylineArticles whose byline prints “M.H. Wan”
  • BylineArticles whose byline prints “R. Li”
  • BylineArticles whose byline prints “X. Wei”
  • BylineArticles whose byline prints “R. Wu”
  • BylineArticles whose byline prints “D.L. Niu”